DK1518930T3 - Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst - Google Patents

Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst

Info

Publication number
DK1518930T3
DK1518930T3 DK04025897T DK04025897T DK1518930T3 DK 1518930 T3 DK1518930 T3 DK 1518930T3 DK 04025897 T DK04025897 T DK 04025897T DK 04025897 T DK04025897 T DK 04025897T DK 1518930 T3 DK1518930 T3 DK 1518930T3
Authority
DK
Denmark
Prior art keywords
methods
compositions
cell growth
neoplastic cell
inhibiting neoplastic
Prior art date
Application number
DK04025897T
Other languages
Danish (da)
English (en)
Inventor
Avi Ashkenazi
Audrey Goddard
Austin L Gurney
Robert D Klein
Mary Napier
William I Wood
Jean Yuan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1518930T3 publication Critical patent/DK1518930T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK04025897T 1998-10-13 1999-10-05 Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst DK1518930T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10408098P 1998-10-13 1998-10-13
PCT/US1999/023089 WO2000021996A2 (en) 1998-10-13 1999-10-05 Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number Publication Date
DK1518930T3 true DK1518930T3 (da) 2007-10-01

Family

ID=22298575

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99970398T DK1121439T3 (da) 1998-10-13 1999-10-05 Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst
DK04025897T DK1518930T3 (da) 1998-10-13 1999-10-05 Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99970398T DK1121439T3 (da) 1998-10-13 1999-10-05 Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst

Country Status (15)

Country Link
EP (1) EP1121439B1 (ko)
JP (1) JP2002527452A (ko)
KR (2) KR100448427B1 (ko)
AT (2) ATE332970T1 (ko)
AU (1) AU758462B2 (ko)
CA (1) CA2344465A1 (ko)
DE (2) DE69932342T2 (ko)
DK (2) DK1121439T3 (ko)
ES (2) ES2290606T3 (ko)
IL (3) IL142088A0 (ko)
MX (1) MXPA01003636A (ko)
NZ (1) NZ510584A (ko)
PT (2) PT1121439E (ko)
WO (1) WO2000021996A2 (ko)
ZA (1) ZA200102380B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
US7049403B2 (en) * 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
BRPI0821600A2 (pt) * 2007-12-28 2015-06-23 Bioinvent Int Ab Composição farmacêutica, artigo de fabricação, kit de partes, método de combater aterosclerose, ou uma doença cardiovascular associada à aterosclerose, e, uso de um anticorpo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
AU9312198A (en) * 1997-09-17 1999-04-05 Genentech Inc. Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
JP2001516580A (ja) * 1997-09-17 2001-10-02 ジェネンテック・インコーポレーテッド 分泌性の、および膜貫通性のポリぺプチド、およびそれをコードする核酸

Also Published As

Publication number Publication date
KR100448426B1 (ko) 2004-09-13
KR100448427B1 (ko) 2004-09-16
DK1121439T3 (da) 2006-11-13
IL142088A (en) 2008-11-26
KR20010085915A (ko) 2001-09-07
ES2268901T3 (es) 2007-03-16
ATE332970T1 (de) 2006-08-15
EP1121439B1 (en) 2006-07-12
AU1200500A (en) 2000-05-01
KR20030096387A (ko) 2003-12-24
CA2344465A1 (en) 2000-04-20
ES2290606T3 (es) 2008-02-16
JP2002527452A (ja) 2002-08-27
DE69936234D1 (de) 2007-07-12
WO2000021996A2 (en) 2000-04-20
IL142088A0 (en) 2002-03-10
PT1518930E (pt) 2007-09-04
WO2000021996A3 (en) 2000-11-09
DE69936234T2 (de) 2008-03-06
DE69932342D1 (de) 2006-08-24
NZ510584A (en) 2003-04-29
MXPA01003636A (es) 2003-10-14
AU758462B2 (en) 2003-03-20
EP1121439A2 (en) 2001-08-08
PT1121439E (pt) 2006-12-29
ZA200102380B (en) 2002-03-22
ATE363536T1 (de) 2007-06-15
IL189502A0 (en) 2008-06-05
DE69932342T2 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
ATE404574T1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
AP9901478A0 (en) Compounds for the treatment of ischemia.
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
NO20012152D0 (no) Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DK0768885T3 (da) Fremgangsmåde til inhibering af cancermetastase ved oral administration af oplöselig modificeret citruspectin
ES2153337T1 (es) Inhibidores de raf-quinasa.
DE69813898D1 (de) Substituierte porphyrinen
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
TR199900310T2 (xx) Trombin inhibit�rleri
IS5856A (is) Aðferðir þar sem integrín-mótlyf eru notuð til aðmeðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla
DK1325011T3 (da) Fremgangsmåder og forbindelser til behandling af proliferative sygdomme
DE69913712D1 (de) Inhibitoren der bakteriellen nad synthetase
ATE386742T1 (de) Imidazonaphthyridine
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
DK0880569T3 (da) Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf
ATE423129T1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DK0950056T3 (da) N-(pyridinylamino)isoindoliner og beslægtede forbindelser
EP1518930A3 (en) Methods and compositions for inhibiting neoplastic cell growth
DK1261325T3 (da) Tumorinhiberende sammensætninger, der indeholder nitroacridiner
MY117925A (en) Compounds for the inhibition of farnesyl protein transferase.
DK0971714T3 (da) Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens
DK1144348T3 (da) LTA4-hydrolaseinhibitorer